Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

Summary

This study aims to evaluate the cognitive enhancing effects and tolerability of GSK239512 compared to placebo in patients with mild to moderate Alzheimer's disease

Timeline

Start

2009-11-02

Primary completion

2010-11-10

Completion

2010-11-10

Drugs

Indications